Dublin, April 15, 2022 (GLOBE NEWSWIRE) -- The "Bone Growth Products Market - Global Outlook & Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.
The global bone growth products market is majorly driven by the rising incidence of bone and joint disorders, growing demand for minimally invasive and non-invasive treatment options for people suffering from various orthopedic disorders, and the growing elderly population.
The bone growth products market by revenue is expected to grow at a CAGR of over 3.60% during the period 2022-2027.
The bone growth stimulator devices segment dominates the global bone growth products market, accounting for a share of 51.12%, followed by bone morphogenetic protein with 39.15% in 2021.
Based on end-users, the market is segmented into hospitals & clinics, specialty orthopedic and spine centers, and ASCs. Hospitals & clinics segment is dominating in the market whereas, specialty orthopedic & spine centers is growing at 4.47% CAGR as patients increasingly prefer specialty spine care centers over multi-specialty hospitals.
The Report Includes:
- The analysis of the global Bone Growth Products market provides market size and growth rate for the forecast period 2022-2027.
- It offers comprehensive insights into current industry trends, trend forecast, and growth drivers about the global Bone Growth Products market.
- The report provides the latest analysis of market share, growth drivers, challenges, and investment opportunities.
- It offers a complete overview of market segments and the regional outlook of the global Bone Growth Products market.
- The report offers a detailed overview of the vendor landscape, competitive analysis, and critical market strategies to gain competitive advantage.
Market Segmentation by Product Type
- Bone Growth Stimulator Device
- Bone Morphogenic Protein
- Platelet Rich Plasma
Market Segmentation by Application
- Spinal Fusion Surgeries
- Oral and Maxillofacial Surgeries
- Delayed Union and Non-Union Bone Fracture
- Others
Market Segmentation by Application
- Hospitals and Clinic
- Specialty Orthopaedic and Spine Center
- Ambulatory Surgery Centers
Global players in the market are adopting acquisition strategies to remain competitive and extend their presence across geographies for higher market share. In addition, the competition among tier II and III players is high, with many regional and local players offering a diverse range of bone growth products.
Prominent Vendors
- Bioventus
- DJO
- Johnson & Johnson
- Medtronic
- Orthofix Medical
- Stryker
- Zimmer Biomet
Other Prominent Vendors
- BTT Health
- Elizur
- Fintek Bio-Electric
- Isto Biologics
- ITO
- Kinex Medical Company
- Ossatec Benelux
- Osteotec
- Paragon 28
- Royal Biologics
- Stimulate Health
- Smith+Nephew
- SpineVision
- VQ OrthoCare
Geographical Analysis
In 2021, North America accounted for a revenue share of 41.45% in the global bone growth products market. The regional market is expected to retain its dominance during the forecast period and is likely to grow at a lesser CAGR than APAC as it has reached maturity.
For more information about this report visit https://www.researchandmarkets.com/r/2nt9ya
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
